Immunohistochemical Study of NR2C2, BTG2, TBX19, and CDK2 Expression in 31 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas

Table 3

The paired recurrent group.

		Recurrence
Primary		Low-	High-	X^2	P
NR2C2	Low-	1(14.3%)	6(85.7%)	4.167	0.031
	High-	0(0%)	24(100%)
BTG2	Low-	31	0	-	-
	High-	0	0
CDK2	Low-	7(77.8%)	2(22.2%)	-	1.000
	High-	1(4.5%)	21(95.5%)
TBX19	Low-	20(71.4%)	8(28.6%)	2.500	0.109
	High-	2(66.7%)	1(33.3%)